Evidence map›Paper›PMID 34052046›Full record

ArticleIndian journal of medical microbiology2021

Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India.

Hardeva Ram Nehara, Inder Puri, Vipin Singhal, Sunil Ih, Bhagirath Ram Bishnoi, Pramendra Sirohi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of medical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hardeva Ram NeharaDepartment of Endocrinology, SP Medical College, Bikaner, Rajasthan, India. Electronic address: drnehara@gmail.com.
Inder PuriDepartment of Neurology, SP Medical College, Bikaner, Rajasthan, India.
Vipin SinghalDepartment of Medicine, SP Medical College, Bikaner, Rajasthan, India.
Sunil IhDepartment of Medicine, SP Medical College, Bikaner, Rajasthan, India.
Bhagirath Ram BishnoiDepartment of Microbiology, SP Medical College, Bikaner, Rajasthan, India.
Pramendra SirohiDepartment of Medicine, SP Medical College, Bikaner, Rajasthan, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), may present with a myriad of clinical manifestations and complications. Patients with COVID-19 are at increased risk of pulmonary thromboembolism, acute cardiac injury, arrhythmias, acute stroke, and secondary infections. Mucormycosis is a catastrophic fungal infection characterized by vascular invasion, thrombosis, and necrosis of tissues. We report five cases of COVID-19 infection, who developed rhino-orbital mucormycosis, during the course of treatment. Early recognition of this life-threatening infection is the key to allow for optimal treatment and improved outcomes.

Indexed as

AgedArrhythmias, CardiacCOVID-19FemaleHumansIndiaMaleMiddle AgedMucormycosisPulmonary EmbolismStrokeCOVID-19MucormycosisRajasthan

Identifiers

PMID34052046
PMCPMC8153224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.